Orexo AB

Orexo AB: Orexo is an integrated pharmaceutical company with commercial operations in the United States and R&D in Sweden developing improved treatments using proprietary drug delivery technology. The company is commercializing its proprietary product, Zubsolv® sublingual tablets, for maintenance treatment of opioid dependence, in the US. The Zubsolv sublingual tablet is a novel formulation of buprenorphine and naloxone using Orexo’s extensive knowledge in sublingual technologies. Orexo has a portfolio of two approved and revenue generating products currently marketed under license in the US, EU and Japan.
Healthcare/Drug Manufacturers
Based in...
Europe, Public
Market Cap
100MM - 500MM
Virdings alle 32 A
P.O. Box 303
Uppsala, 75105

Company Participants at Carnegie Nordic Healthcare Day

Robert DeLuca
Orexo AB, President
Other appointments: Member of the St. John’s College of Pharmacy Dean’s Advisory Board, American Society of Addiction Medicine, Academy of Managed Care Pharmacy and the American and New Jersey Pharmacists Associations. Previous appointments: Extensive experience establishing commercial operations in the US with a combined background in market access, marketing, and sales. Has held leadership positions at multinational pharmaceutical companies including Sanofi-Aventis, ScheringPlough, Berlex and Pharmacia, and most recently served as Chief Commercial Officer at Archimedes Pharmaceuticals. Holds 2,703 shares and stock options entitled to 238,931 shares, as of December 31 2016.

Top 10 Holders of Orexo AB

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Sjätte AP-fonden 2.22 768,850 0.00 Stakes 8/31/21
GVC Gaesco Gestión SGIIC SA 0.07 22,998 0.00 Funds 6/30/21
FCG Fonder AB 0.00 1,527 0.00 Funds 8/31/21
American Century Investment Management, Inc. 0.01 3,770 0.00 Funds 9/30/21
Dimensional Fund Advisors Ltd. 0.02 8,110 0.00 Funds 5/31/21
Catella Fondförvaltning AB 0.02 8,650 0.00 Funds 9/30/21
Dimensional Fund Advisors LP 0.04 12,783 0.00 Funds 8/31/21
Consultinvest Asset Management SGR SpA 0.06 22,000 0.00 Funds 9/30/21
Storebrand Asset Management AS 0.11 39,889 0.00 Funds 9/30/21
Fjärde AP-fonden 1.86 646,328 0.00 Stakes 8/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.